[
  {
    "ts": null,
    "headline": "Eli Lilly Uses GLP 1 Strength To Build Broader Drug Pipeline",
    "summary": "Eli Lilly (NYSE:LLY) plans to invest over US$3.5b in a new Pennsylvania manufacturing facility focused on next generation injectable weight loss therapies. The company announced new collaborations with Repertoire Immune Medicines for autoimmune disease programs and Seamless Therapeutics for gene editing treatments aimed at hearing loss. Lilly also received FDA Breakthrough Therapy designation for its ovarian cancer drug candidate sofetabart mipitecan. Eli Lilly is active in several fast...",
    "url": "https://finnhub.io/api/news?id=cc77dbc6d0f505d39619ffbf8e2ad0c0181d4d19a390914dda129316b7eb5578",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769893590,
      "headline": "Eli Lilly Uses GLP 1 Strength To Build Broader Drug Pipeline",
      "id": 138319084,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly (NYSE:LLY) plans to invest over US$3.5b in a new Pennsylvania manufacturing facility focused on next generation injectable weight loss therapies. The company announced new collaborations with Repertoire Immune Medicines for autoimmune disease programs and Seamless Therapeutics for gene editing treatments aimed at hearing loss. Lilly also received FDA Breakthrough Therapy designation for its ovarian cancer drug candidate sofetabart mipitecan. Eli Lilly is active in several fast...",
      "url": "https://finnhub.io/api/news?id=cc77dbc6d0f505d39619ffbf8e2ad0c0181d4d19a390914dda129316b7eb5578"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY) Earns Fresh Bullish Calls from Analysts",
    "summary": "Eli Lilly and Company (NYSE:LLY) is among the most profitable healthcare stocks to buy. On January 26, Srikripa Devarakonda, an analyst at Truist Financial, maintained a Buy rating on Eli Lilly and Company (NYSE:LLY), while setting a price target of $1,182. This reflects an upside potential of 11%. Earlier, on January 20, Bernstein maintained an Outperform […]",
    "url": "https://finnhub.io/api/news?id=e9dd468546550f251b1505811d191deec5dc6a9f8c722044d775b8323dda9d9c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769880948,
      "headline": "Eli Lilly and Company (LLY) Earns Fresh Bullish Calls from Analysts",
      "id": 138316636,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE:LLY) is among the most profitable healthcare stocks to buy. On January 26, Srikripa Devarakonda, an analyst at Truist Financial, maintained a Buy rating on Eli Lilly and Company (NYSE:LLY), while setting a price target of $1,182. This reflects an upside potential of 11%. Earlier, on January 20, Bernstein maintained an Outperform […]",
      "url": "https://finnhub.io/api/news?id=e9dd468546550f251b1505811d191deec5dc6a9f8c722044d775b8323dda9d9c"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly and Company (LLY) Expands U.S. Manufacturing and Advances Breakthrough Therapies",
    "summary": "Eli Lilly and Company (NYSE:LLY) is one of the best healthcare stocks to buy for 2026. On January 29, Reuters reported that U.S. President Donald Trump said Eli Lilly plans to build six new manufacturing plants in the United States. Lilly previously announced it would invest at least $27 billion to expand production and strengthen […]",
    "url": "https://finnhub.io/api/news?id=c3a6dc262e1148c49db7e188d502d1a40d5ca3dd97f2c65d90a721e6f2653461",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769870151,
      "headline": "Eli Lilly and Company (LLY) Expands U.S. Manufacturing and Advances Breakthrough Therapies",
      "id": 138315762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the best healthcare stocks to buy for 2026. On January 29, Reuters reported that U.S. President Donald Trump said Eli Lilly plans to build six new manufacturing plants in the United States. Lilly previously announced it would invest at least $27 billion to expand production and strengthen […]",
      "url": "https://finnhub.io/api/news?id=c3a6dc262e1148c49db7e188d502d1a40d5ca3dd97f2c65d90a721e6f2653461"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (LLY) Taps Gene-Editing Technology to Target Hearing Loss, Reuters Reports",
    "summary": "Eli Lilly and Company (NYSE:LLY) is included among the 12 Best Stocks to Buy for the Long Term. According to a report by Reuters, Eli Lilly and Company (NYSE:LLY) has signed an agreement worth up to $1.12 billion with Seamless Therapeutics. The Germany-based startup announced the deal on January 28. The partnership focuses on developing […]",
    "url": "https://finnhub.io/api/news?id=2cf7ae4922e01f925ead50c3b127b5063f1284663d8ac8f783c729e7e4dcdc9d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769867024,
      "headline": "Eli Lilly (LLY) Taps Gene-Editing Technology to Target Hearing Loss, Reuters Reports",
      "id": 138315117,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly and Company (NYSE:LLY) is included among the 12 Best Stocks to Buy for the Long Term. According to a report by Reuters, Eli Lilly and Company (NYSE:LLY) has signed an agreement worth up to $1.12 billion with Seamless Therapeutics. The Germany-based startup announced the deal on January 28. The partnership focuses on developing […]",
      "url": "https://finnhub.io/api/news?id=2cf7ae4922e01f925ead50c3b127b5063f1284663d8ac8f783c729e7e4dcdc9d"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Novo Nordisk Stock on Oral Wegovy's Strong Launch?",
    "summary": "This could finally be the start of the drugmaker's comeback.",
    "url": "https://finnhub.io/api/news?id=192f00e24b0db7015a14b0154a9cb01d6e42b03c000908cfb543211892cb7e6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769861100,
      "headline": "Should You Buy Novo Nordisk Stock on Oral Wegovy's Strong Launch?",
      "id": 138315118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "This could finally be the start of the drugmaker's comeback.",
      "url": "https://finnhub.io/api/news?id=192f00e24b0db7015a14b0154a9cb01d6e42b03c000908cfb543211892cb7e6d"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet, Amazon, AMD Lead Earnings Wave; Jobs Data On Deck",
    "summary": "Wall Street Week Ahead: key earnings (Amazon, Alphabet), IPOs, dividends & economic data (NFP, PMI). Read here for more details.",
    "url": "https://finnhub.io/api/news?id=b3e63802df6853657bf27d4f27978ea3f127e889b8b510bff3c097715be8804b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769857200,
      "headline": "Alphabet, Amazon, AMD Lead Earnings Wave; Jobs Data On Deck",
      "id": 138315868,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Wall Street Week Ahead: key earnings (Amazon, Alphabet), IPOs, dividends & economic data (NFP, PMI). Read here for more details.",
      "url": "https://finnhub.io/api/news?id=b3e63802df6853657bf27d4f27978ea3f127e889b8b510bff3c097715be8804b"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Futures: Market Tests Key Levels In Risk-Off Shift; Google, AMD, Amazon, Palantir On Tap",
    "summary": "The stock market tested key levels to end the week while gold and silver dived in a risk-off shift. Google, AMD, Eli Lilly, Amazon and Palantir headline another big earnings week.",
    "url": "https://finnhub.io/api/news?id=dd916f1ad2a3d665bfc64b2b55c57b5af4595a9348d32b83e8fee695f0b31845",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769817663,
      "headline": "Dow Jones Futures: Market Tests Key Levels In Risk-Off Shift; Google, AMD, Amazon, Palantir On Tap",
      "id": 138312095,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "The stock market tested key levels to end the week while gold and silver dived in a risk-off shift. Google, AMD, Eli Lilly, Amazon and Palantir headline another big earnings week.",
      "url": "https://finnhub.io/api/news?id=dd916f1ad2a3d665bfc64b2b55c57b5af4595a9348d32b83e8fee695f0b31845"
    }
  }
]